The High-flow Nasal Cannula Practices of Pediatric Intensive Care and Pediatric Emergency Specialists in Turkey


Creative Commons License

ÜDÜRGÜCÜ M., YENER N., ALBAYRAK H.

Çocuk Acil ve Yoğun Bakım Dergisi, cilt.9, sa.3, ss.162-167, 2022 (Scopus) identifier identifier

Özet

Introduction: To date, no consensus has been reached on the start, monitoring and termination methods for high-flow nasal cannula oxygen (HFNC) treatment in children. Therefore the aim of this study was to evaluate the HFNC practices of pediatric emergency and pediatric intensive care specialists in Turkey. Methods: A total of 85 pediatric emergency and pediatric intensive care specialists from 22 cities participated in this questionnaire study. The questionnaire consisted of 20 items related to HFNC indications, complications, preferred settings, follow-up and weaning methods. Results: To start HFNC, 22.4% of the respondents reported using a scoring system. It was reported with FiO2 >50% by 57.6% and <50% by 42.4% of the respondents. The decision to terminate HFNC was stated to be based on a scoring system by 31.7%. It was stated by 91.8% of respondents that HFNC treatment was terminated by reducing the flow, and 8.2% directly terminated the treatment. The most common indication for HFNC was acute bronchiolitis in both the emergency department and pediatric intensive care. Conclusion: It was determined that the majority of pediatric emergency and pediatric intensive care specialists based their decisions for starting, monitoring and terminating HFNC on the examination findings of the patient and did not use any scoring system or protocol.